StockData
Evolus, Inc. logo

Evolus, Inc. (EOLS) stock

EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$6.69+0.06 (+0.90%)

Close on Nov 17, 2026Market cap $441.88MP/E –Yield –

Evolus price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Evolus's price to book ratio was 131.1× on Apr 30, 2025, against 82.0× a year earlier. Over the last 5 years it ranged from 1.8× to 167.8×, with a median of 10.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 2025131.1×+12.5
2024Dec 31, 2024118.6×+36.5
2023Jul 31, 202382.0×+67.6
2022Dec 30, 202214.4×+10.7
2021Dec 31, 20213.7×+0.5
2020Dec 31, 20203.2×−16.4
2019Dec 31, 201919.6×+16.2
2018Dec 31, 20183.4×–

More Evolus figures

See a number that looks wrong?